PMA Submission Cost: Complete 2026 Budget Breakdown for Class III Devices

Why PMA Is the Most Expensive Regulatory Pathway

The FDA's Premarket Approval (PMA) process is the most rigorous and costly regulatory pathway for medical devices. Required for Class III devices — those that support or sustain human life, are substantially important in preventing impairment of health, or present potential unreasonable risk — PMA demands comprehensive scientific evidence of safety and effectiveness.

The total cost of bringing a Class III device from concept through PMA approval typically ranges from $10 million to over $100 million, with clinical trials accounting for the largest share. For comparison, a 510(k) submission costs $30,000 to $500,000, and a De Novo falls between $50,000 and $2 million.

This guide breaks down every cost component of a PMA submission with FY 2026-specific figures. Whether you are a startup planning your first PMA or an established manufacturer budgeting for a new Class III device, use this to build an accurate budget that accounts for all expenses — not just the FDA user fee.

FY 2026 FDA User Fees for PMA

The FDA charges substantial user fees for PMA submissions under the Medical Device User Fee Amendments (MDUFA V). For FY 2026 (October 1, 2025 through September 30, 2026):

PMA-Related FDA Fee Schedule

Submission Type	Standard Fee	Small Business Fee (25%)	Notes
Original PMA / PDP / PMR / BLA	$579,272	$144,818	The single largest direct fee
Panel-track supplement	$463,418	$115,855	Major changes to approved device
180-day supplement	$86,891	$21,723	Moderate changes
Real-time supplement	$40,549	$10,137	Minor manufacturing changes
30-day notice	$9,268	$4,634	Manufacturing site/process changes
Annual periodic reporting (Class III)	$20,275	$5,069	Required every year for each PMA
Establishment registration (annual)	$11,423	$11,423 (no reduction)	Per establishment

Key observations for FY 2026:

• The PMA fee represents a 7.12% increase from FY 2025 ($540,783 standard)
• The establishment registration fee jumped 23% from FY 2025 ($9,280)
• Small business qualification (gross receipts ≤ $100M) reduces the fee to 25% of standard
• Businesses with gross receipts ≤ $30M may qualify for a one-time first PMA fee waiver — potentially saving $579,272

Small Business Fee Relief

The FDA offers significant fee relief for qualifying small businesses:

Qualification	Benefit
Gross receipts ≤ $100M (including affiliates)	Reduced fee (25% of standard)
Gross receipts ≤ $30M (including affiliates)	First PMA/PDP/PMR/BLA fee waived entirely
Gross receipts ≤ $1M, prior registration paid, financial hardship	Potential establishment registration fee waiver (FY 2026 new provision)

Submit your Small Business Determination (SBD) request at least 60 days before your planned submission date.

Total Cost Breakdown: Concept to Approval

The FDA user fee is a fraction of the total PMA investment. Below is a comprehensive breakdown of all cost components from concept through approval.

Cost Summary by Phase

Phase	Typical Cost Range	% of Total Budget
Concept and feasibility	$500K - $5M	5-8%
Pre-clinical development and testing	$1M - $10M	10-15%
Clinical trials	$5M - $50M+	40-60%
PMA submission preparation	$500K - $2M	8-12%
FDA user fees and interactions	$580K - $700K	3-5%
Manufacturing scale-up and validation	$1M - $5M	10-15%
Post-approval compliance setup	$500K - $2M	5-8%
Total	$10M - $75M+	100%

Concept and Feasibility Phase: $500K - $5M

This phase establishes whether the device concept is viable and defines the regulatory strategy.

Cost Component	Typical Range
Market research and competitive analysis	$50K - $200K
Intellectual property searches and filing	$50K - $150K
Initial prototype development	$100K - $1M
Feasibility studies and concept testing	$100K - $500K
Regulatory strategy development	$50K - $200K
FDA pre-submission meetings (Q-Submission)	$50K - $150K (preparation costs; no FDA fee)
Reimbursement strategy	$50K - $200K

Critical investment: The FDA pre-submission meeting (Q-Submission) is free in terms of user fees but requires significant preparation. Invest in thorough pre-submission packages — the feedback you receive on study design, endpoints, and data requirements can save millions in misdirected clinical development.

Pre-Clinical Development and Testing: $1M - $10M

Before clinical trials can begin, the device must undergo rigorous laboratory and animal testing.

Testing Category	Typical Cost Range	Timeline
Design verification testing	$200K - $2M	3-6 months
Biocompatibility testing (ISO 10993 series)	$50K - $300K	2-6 months
Mechanical / performance testing	$100K - $1M	2-6 months
Electrical safety and EMC (IEC 60601)	$30K - $100K	1-3 months
Animal studies	$200K - $2M	3-12 months
Software verification and validation (IEC 62304)	$100K - $500K	3-6 months
Sterilization validation	$50K - $200K	2-4 months
Usability testing (IEC 62366)	$50K - $200K	2-4 months

Cost note: Animal studies for PMA devices are often the largest single pre-clinical expense. A well-designed animal study that satisfies FDA requirements can cost $500K-$2M. Multiple studies or iterative testing can push this to $3M+.

Clinical Trials: $5M - $50M+

Clinical trials are the dominant cost driver for PMA submissions, typically representing 40-60% of the total budget. The FDA requires "reasonable evidence of safety and effectiveness" for PMA approval, which almost always means clinical data from controlled investigations.

Clinical Trial Cost Breakdown

Clinical Phase	Typical Cost	Purpose
Pilot / Feasibility Study	$700K - $5M	First-in-human, preliminary safety, design refinement
Pivotal Study	$5M - $50M+	Primary evidence for safety and effectiveness
IDE preparation and FDA interaction	$150K - $300K	Investigational Device Exemption application

Pivotal Study Cost Components

Cost Component	Typical Range	Notes
Per-patient costs	$12K - $50K+ per patient	Depends on follow-up duration, procedures, endpoints
Site initiation and activation	$30K - $80K per site	Includes IRB fees, site contracts, training
CRO (Contract Research Organization)	$500K - $5M	Project management, monitoring, data management
Data management and biostatistics	$200K - $1M	Database design, cleaning, statistical analysis plan
Investigator grants	$300K - $3M	Per-site payments for patient enrollment and follow-up
Core laboratory (imaging, pathology)	$100K - $500K	Centralized reading of study endpoints
IRB / Ethics committee fees	$50K - $200K	Across all investigational sites
Clinical monitoring	$300K - $2M	Source data verification, site visits
Regulatory and IDE support	$150K - $500K	IDE application, amendments, reporting
Patient insurance and safety monitoring	$50K - $300K	DSMB, adverse event reporting

Realistic pivotal study example — Implantable cardiovascular device:

• 200-400 patients across 20-40 sites
• 12-month primary endpoint with 2-5 year follow-up
• Per-patient cost: ~$25,000-$40,000
• Total pivotal study cost: $15M-$40M

Factors That Drive Clinical Trial Costs

Factor	Impact on Cost
Number of patients	Linear — more patients = proportionally higher costs
Number of clinical sites	Semi-linear — each site has fixed startup + variable patient costs
Follow-up duration	Linear — each additional year adds 15-25% to total study cost
Complexity of endpoints	Major — imaging, histopathology, and functional endpoints cost significantly more than clinical scores
Regulatory region	US sites cost 30-50% more than EU/Asia Pacific sites on a per-patient basis
Enrollment rate	Inverse — slow enrollment increases per-patient cost due to fixed CRO and site overhead

PMA Submission Preparation: $500K - $2M

The PMA application itself is a massive document — typically 1,000-5,000+ pages covering every aspect of the device's design, manufacturing, testing, and clinical evidence.

Preparation Component	Typical Cost Range
Regulatory writing and compilation	$200K - $800K
Clinical data analysis and reporting	$100K - $500K
Manufacturing section (process validation, site documentation)	$100K - $300K
Labeling development	$50K - $150K
Risk analysis (ISO 14971) compilation	$30K - $100K
Quality system documentation for BIMO inspection readiness	$50K - $200K
Internal review and quality checks	$30K - $100K

FDA Review Process: Direct and Indirect Costs

Beyond the user fee, the FDA review process generates additional costs:

Cost Item	Typical Range
FDA user fee (original PMA)	$579,272 (standard) / $144,818 (small business)
FDA advisory panel preparation	$50K - $200K (if panel meeting required)
Response to FDA deficiency letters	$50K - $300K per cycle
FDA inspection readiness (pre-approval inspection)	$50K - $200K
Establishment registration	$11,423

Timeline: The FDA's target is 180 review days for PMA applications. In practice, the total process from submission to decision often takes 12-24 months, including time for FDA questions, sponsor responses, advisory panel meetings (if convened), and re-inspections.

PMA Supplement Costs: Post-Approval Changes

After PMA approval, any changes to the device, manufacturing process, or labeling require a PMA supplement. The type of supplement depends on the significance of the change.

Supplement Type	When Required	FY 2026 Standard Fee	Typical Preparation Cost	Total Cost
Panel-track	Significant changes in design, materials, energy source, or indications	$463,418	$100K - $500K	$563K - $963K
180-day	Moderate changes not requiring panel review	$86,891	$50K - $200K	$137K - $287K
Real-time	Minor manufacturing changes	$40,549	$20K - $100K	$60K - $141K
30-day notice	Manufacturing process/site changes	$9,268	$5K - $30K	$14K - $39K
Annual report	Minor changes, labeling updates, minor design changes	$20,275 (periodic reporting fee)	$10K - $50K	$30K - $70K

Budgeting for the product lifecycle: Over a 10-year product life, a typical PMA device will require 5-15 supplements and annual reports. Budget $500K-$2M for post-approval regulatory changes beyond the initial approval.

Cost Comparison: PMA vs Other FDA Pathways

Factor	PMA	De Novo	510(k)
FDA user fee (FY 2026)	$579,272 / $144,818 SB	$173,782 / $43,446 SB	$26,067 / $6,517 SB
Total cost (concept to clearance)	$10M - $100M+	$500K - $5M+	$30K - $500K+
Timeline	4-8+ years	1-3 years	6-18 months
Clinical data	Almost always required (pivotal study)	Sometimes required	Rarely required
Annual reporting cost	$20,275 / $5,069 SB	Standard post-market	Standard post-market
FDA inspection frequency	At least annually	Routine	Risk-based

Post-Approval Compliance Costs

PMA approval is not the end of your financial commitment. Class III devices have the most extensive post-market obligations of any device category.

Ongoing Requirement	Annual Cost Estimate
Periodic reporting (annual reports to FDA)	$20,275 fee + $20K-$100K preparation
Post-approval studies (if required)	$500K - $5M+ per year
Medical device reporting (MDR)	$50K - $200K
Post-market surveillance	$100K - $500K
Quality system maintenance (ISO 13485 / QMSR)	$50K - $300K
FDA inspections (at least annual)	$30K - $150K preparation per inspection
Labeling and advertising compliance	$20K - $100K

Annual post-approval budget: $750K - $6M+ per year depending on post-approval study requirements and inspection findings.

Strategies for Reducing PMA Costs

1. Maximize Early FDA Engagement

Pre-submission meetings are free (no user fee) and the single most valuable cost-saving tool. A well-prepared pre-submission package that results in FDA agreement on your study design, endpoints, and statistical analysis plan can save $1M-$10M by preventing redesign of clinical trials.

2. Qualify for Small Business Status

If eligible, the small business fee reduction saves $434,454 on the original PMA fee. If your company has ≤$30M in gross receipts, the first PMA fee waiver saves the entire $579,272.

3. Consider Breakthrough Device Designation

The FDA's Breakthrough Device Program provides priority review, more interactive communication with FDA staff, and expedited processing. While it does not reduce user fees, it can significantly reduce the time (and therefore cost) of the review process. Devices that receive Breakthrough Designation have been shown to reach market 6-18 months faster.

4. Design Efficient Clinical Trials

• Use adaptive trial designs that allow mid-study adjustments without full protocol amendments
• Conduct multi-center studies in regions with lower per-patient costs (with FDA agreement)
• Use Bayesian statistical approaches where appropriate to reduce required sample size
• Leverage real-world evidence to supplement or replace some primary data collection

5. Build Regulatory Expertise In-House

Regulatory consultants for PMA submissions charge $200-$500/hour, with full-service PMA preparation costing $500K-$2M. Building an experienced internal regulatory team, while expensive in salaries, is more cost-effective over multiple PMA submissions.

Budget Planning Checklist

Pre-Submission Phase

• FDA user fee ($579,272 standard / $144,818 small business / $0 first-time waiver)
• Small Business Determination application (60 days before submission)
• Pre-submission meetings (Q-Submission preparation: $50K-$150K each)
• Regulatory strategy development ($50K-$200K)

Development and Testing Phase

• Design verification testing ($200K-$2M)
• Biocompatibility testing ($50K-$300K)
• Performance / mechanical testing ($100K-$1M)
• Animal studies ($200K-$2M)
• Software V&V ($100K-$500K)
• Usability testing ($50K-$200K)
• Sterilization validation ($50K-$200K)

Clinical Trial Phase

• IDE application preparation ($150K-$300K)
• Pilot / feasibility study ($700K-$5M)
• Pivotal study ($5M-$50M+)
• CRO services ($500K-$5M)
• Data management and biostatistics ($200K-$1M)

Submission Phase

• PMA writing and compilation ($200K-$800K)
• Clinical data analysis ($100K-$500K)
• Manufacturing documentation ($100K-$300K)
• Labeling development ($50K-$150K)
• Advisory panel preparation ($50K-$200K, if needed)
• Inspection readiness ($50K-$200K)

Post-Approval Phase

• Annual periodic reporting fee ($20,275 / $5,069 SB per year)
• Post-approval studies (if required) ($500K-$5M+/year)
• Quality system maintenance ($50K-$300K/year)
• FDA inspection preparation ($30K-$150K/inspection)

Frequently Asked Questions

Can I get a refund on the PMA user fee if my application is not approved?

No. The FDA does not refund user fees regardless of outcome. However, if your PMA receives a "not approvable" letter, you can submit additional information to address the deficiencies without paying a new user fee, provided the response is submitted within the timeframe specified by FDA.

How long does the PMA process take?

The FDA's target is 180 review days. In practice, the total process from submission to decision typically takes 12-24 months, including time for FDA questions, sponsor responses, potential advisory panel meetings, and pre-approval inspections. The total development timeline from concept to approval is typically 4-8+ years.

Is clinical data always required for a PMA?

Almost always. The FDA requires "reasonable evidence of safety and effectiveness" for PMA devices, which in practice means data from a well-controlled clinical investigation. In rare cases, extensive bench testing, animal data, and real-world evidence may be sufficient, but this is the exception. Budget for clinical trials.

What happens if the FDA convenes an advisory panel?

If the FDA convenes an advisory panel for your PMA, you will need to prepare presentations, respond to panel questions, and potentially provide additional data. Panel preparation typically costs $50K-$200K in consulting fees and requires significant senior leadership time. Panel meetings are public and the panel's recommendation (while not binding) heavily influences the FDA's decision.

Can a startup afford a PMA?

PMA is extremely capital-intensive. Most startups pursuing Class III devices raise $25M-$100M+ in venture funding before reaching market. The clinical trial costs alone can exceed $10M. However, strategies like Breakthrough Device Designation, small business fee waivers, and phased clinical development can reduce the capital required. Some startups pursue a De Novo classification first (if eligible) to establish a predicate, making future similar devices eligible for the 510(k) pathway.

How do PMA supplement costs compare to the original PMA?

Panel-track supplements ($463,418) approach the cost of some 510(k) submissions. Even 180-day supplements ($86,891) represent significant ongoing expenses. Over a product's lifetime, total supplement costs can reach $2M-$5M or more. Budget for post-approval changes as a routine cost of doing business with a Class III device.

---

Key Takeaways

1. The FDA PMA user fee is $579,272 (standard) or $144,818 (small business) for FY 2026, but this represents only 3-5% of the total investment required for most PMA devices
2. Clinical trials are the dominant cost driver at 40-60% of total budget, typically ranging from $5M to $50M+ for pivotal studies
3. Total PMA costs from concept to approval range from $10M to over $100M, with a typical timeline of 4-8+ years
4. Small businesses can save significantly: fee reductions (25% of standard) for companies with ≤$100M revenue, and complete first-PMA fee waivers for companies with ≤$30M revenue
5. Post-approval costs are substantial: budget $750K-$6M+ per year for annual reporting, post-approval studies, inspections, and compliance maintenance
6. Early FDA engagement through pre-submission meetings is the single most effective cost-saving strategy, potentially saving $1M-$10M by preventing misdirected clinical development